Epitalon is a synthetic tetrapeptide designed to mimic epithalamin, a peptide naturally produced by the pineal gland. Its primary proposed mechanism for healthspan is the upregulation of the telomerase enzyme, which helps maintain or lengthen telomeres, the protective caps on the ends of chromosomes. By counteracting telomere shortening, a hallmark of cellular aging, Epitalon is theorized to slow age-related decline and extend cellular lifespan.
Verdict
A highly speculative peptide with significant safety and evidence concerns.
HEALTHSPAN IMPACT
Experimental
RISK LEVEL
High
EVIDENCE GRADE
C
MONTHLY COST
$75 - $200
Protocol
- A common cycle is 10 mg daily via subcutaneous injection for 10-20 days, repeated every 6 months.
Flags
- Not approved for human use by the FDA or EMA.
- Sourced from unregulated 'research chemical' suppliers, risking purity and contamination issues.
- Most supporting research originates from a single institution with limited independent validation.
- Long-term effects of telomerase activation, including theoretical cancer risk, are unknown.